SecBot SecBot
← Back to Analyst Consensus
SGMO Buy

SANGAMO THERAPEUTICS, INC

Current Price —
Implied Upside —
Analysts 7

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 4, 2026 (9 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Feb 10, 2026HC Wainwright & Co.reiterateBuy → Buy$1044%
Nov 7, 2025BarclaysdowngradeOverweight → Equal-Weight$153%
Sep 4, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Jun 24, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
May 14, 2025BarclaysmaintainOverweight → Overweight$553%
Apr 7, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Mar 18, 2025RBC CapitalreiterateSector Perform → Sector Perform$255%
Jan 27, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Jan 23, 2025Truist SecuritiesmaintainBuy → Buy$554%
Jan 2, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Dec 31, 2024JefferiesmaintainBuy → Buy$352%
Dec 31, 2024Wells FargomaintainEqual-Weight → Equal-Weight$254%
Dec 20, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Dec 19, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Dec 10, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Nov 14, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Nov 14, 2024BarclaysmaintainOverweight → Overweight$953%
Nov 5, 2024HC Wainwright & Co.maintainBuy → Buy$1044%
Oct 23, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Oct 22, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Aug 22, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Jul 31, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Jul 24, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
May 15, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Mar 19, 2024HC Wainwright & Co.reiterateBuy → Buy$544%
Mar 14, 2024RBC CapitalreiterateSector Perform → Sector Perform$255%
Mar 13, 2024HC Wainwright & Co.maintainBuy → Buy$344%
Feb 12, 2024HC Wainwright & Co.reiterateBuy → Buy$344%
Feb 6, 2024HC Wainwright & Co.reiterateBuy → Buy$344%
Jan 19, 2024HC Wainwright & Co.reiterateBuy → Buy$344%
Nov 7, 2023Truist SecuritiesdowngradeBuy → Hold$054%
Nov 6, 2023HC Wainwright & Co.maintainBuy → Buy$344%
Nov 6, 2023Wells FargodowngradeOverweight → Equal-Weight$154%
Nov 3, 2023RBC CapitaldowngradeOutperform → Sector Perform$255%
Aug 15, 2023Truist SecuritiesmaintainBuy → Buy$754%
Aug 14, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Aug 11, 2023WedbushmaintainOutperform → Outperform$1058%
Aug 10, 2023Wells FargomaintainOverweight → Overweight$454%
Aug 9, 2023BarclaysmaintainOverweight → Overweight$953%
Aug 9, 2023RBC CapitalmaintainOutperform → Outperform$655%
May 10, 2023Truist SecuritiesmaintainBuy → Buy$854%
May 1, 2023HC Wainwright & Co.maintain— → Buy$544%
Apr 28, 2023B of A SecuritiesdowngradeNeutral → Underperform$1.553%
Mar 3, 2023HC Wainwright & Co.maintain— → Buy$1544%
Feb 27, 2023WedbushupgradeNeutral → Outperform$1658%
Feb 23, 2023RBC Capitalmaintain— → Outperform$1355%
Jan 4, 2023Wells Fargomaintain— → Overweight$1554%
Nov 7, 2022Wells Fargomaintain— → Overweight$2054%
Apr 5, 2022Truist Securitiesmaintain— → Buy$1954%
May 4, 2021RBC Capitalinitiate— → Outperform$2255%

Price Target Trend

Mar 30, 2026 Latest: $1.5 Aug 29, 2026

EPS Estimates

0q $-0.07
Lo: $-0.07 Hi: $-0.07
1 analysts
▲1
0y $-0.30
Lo: $-0.30 Hi: $-0.30
1 analysts
▲1
+1q $-0.08
Lo: $-0.08 Hi: $-0.08
1 analysts
▲1
+1y $-0.10
Lo: $-0.10 Hi: $-0.10
1 analysts
▲1

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access